The present invention relates to medical pumps for delivering medicament to a patient and, more specifically, to a drive mechanism for a user-wearable pump, such as a patch pump, for delivering medicament such as insulin to a patient.
There are many applications in academic, industrial, and medical fields that benefit from devices and methods that are capable of accurately and controllably delivering fluids, such as liquids and gases, that have a beneficial effect when administered in known and controlled quantities. Such devices and methods can be particularly useful in the medical field where treatments for many patients include the administration of a known amount of a substance at predetermined intervals.
One category of devices for delivering such fluids is that of pumps that have been developed for the administration of insulin and other medicaments for those suffering from both type I and type II diabetes. Some pumps configured as portable infusion devices can provide continuous subcutaneous medicament injection and/or infusion therapy for the treatment of diabetes. Such therapy may include, e.g., the regular and/or continuous injection or infusion of insulin into a person suffering from diabetes and offer an alternative to multiple daily injections of insulin by an insulin syringe or an insulin pen. Such pumps can be ambulatory/portable infusion pumps that are worn by the user and may use replaceable cartridges. Such pumps can deliver medicaments other than or in addition to insulin, such as glucagon. Examples of such pumps and various features that can be associated with such pumps include those disclosed in U.S. Patent Application Publication No. 2013/0053816, U.S. Pat. Nos. 8,573,027, 8,986,253, U.S. Patent Application Publication No. 2013/0324928, U.S. Patent Application Publication No. 2013/0331790 and U.S. Pat. No. 8,287,495, each of which is hereby incorporated herein by reference in its entirety.
One type of pump that has been developed is a patch pump, or micro pump. Patch pumps generally are small pumps, typically ambulatory, that are carried directly on the skin under the user's clothing. Many such pumps are situated directly on the infusion site such that no tubing is required to deliver the insulin and/or other medicament to the patient. Other patch pumps can be positioned on the patient's body with a short length of tubing extending to a nearby infusion site. Not unlike other types of pumps, but perhaps more typically, patch pumps can be at least in part disposable, meant to be worn for a period of time such as, e.g., a day or two, and then discarded and replaced by a new patch pump. Other patch pump designs contemplate a disposable component, such as a cartridge that contains medicament, and a reusable or durable component. In such configurations, the disposable and durable components may be joined together by the patient or caregiver in preparation for delivery of the medicament.
A patch pump utilizes piezoelectricity to dispense medicament from a cartridge syringe to a patient. Pump can include a plurality of piezoelectric elements that when energized cause linear motion of a pushrod that interfaces with the syringe in the cartridge to advance the syringe and dispense the medicament. The high torque generated by the piezoelectric elements is directly converted into the same amount of torque on the lead screw, so no torque increasing gear reduction system is needed and the pushrod utilized to drive the syringe can be contained within and connected directly to the motor assembly. Such a piezoelectric-based system can therefore be made smaller and with fewer moving parts than an electromagnetic motor of the same capability such that the pump has a smaller size than has heretofore been possible with prior art electromagnetic-based syringe pumps and other pumps that utilize gear reduction systems.
In some embodiments, a user-wearable infusion pump includes a disposable cartridge and a drive unit. The disposable cartridge can include a reservoir configured to contain a medicament, a plunger at a proximal end of the reservoir and an outlet port in fluid communication with the reservoir. The drive unit can include at least one piezoelectric motor and a pushrod and be configured such that when the piezoelectric motor is energized with an electrical drive signal, it causes linear motion of the pushrod that moves the plunger to cause medicament to flow from the reservoir out of the outlet port to a patient without a gear reduction system.
In some embodiments, a user-wearable infusion pump includes a disposable cartridge and a drive unit. The disposable cartridge can include a reservoir configured to contain a medicament, a plunger at a proximal end of the reservoir and an outlet port in fluid communication with the reservoir. The drive unit can include a drive disk having a body defining a central opening through which a drive tube extends such that rotation of the drive disk caused by a motor causes rotation of the drive tube. An externally threaded lead screw can be coupled to the drive tube such that rotation of the drive tube causes rotation of the lead screw. A pushrod having a distal tip can have internal threads configured to mate with the externally threaded lead screw and a guide bushing can surround a portion of the pushrod to prevent rotation of the pushrod such that rotation of the drive screw causes linear motion of the pushrod. Thus, when the motor is actuated to rotate the drive disk, the pushrod is linearly advanced such that the distal tip contacts the plunger in the cartridge and moves the plunger to dispense medicament from the reservoir out the outlet port.
In some embodiments, a user-wearable infusion pump, includes a reservoir configured to contain a medicament, an outlet port in fluid communication with the reservoir, at least one piezoelectric motor and a pushrod. When the at least one piezoelectric motor is energized with an electrical drive signal, it causes linear motion of the pushrod without a gear reduction system that causes medicament to flow from the reservoir out of the outlet port to a patient.
The above summary is not intended to describe each illustrated embodiment or every implementation of the subject matter hereof. The figures and the detailed description that follow more particularly exemplify various embodiments.
Subject matter hereof may be more completely understood in consideration of the following detailed description of various embodiments in connection with the accompanying figures, in which:
While various embodiments are amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the claimed inventions to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the subject matter as defined by the claims.
In some embodiments, and as shown in
Also depicted in the embodiment of
In the depicted embodiment, the piezoelectric elements that drive the system are three piezoelectric crystal motors 201 contained within the drive mechanism 122, although it should be understood that greater or fewer numbers of motors could be used. One type of piezoelectric motor that may be used in various embodiments of the present invention is the Edge Motor sold by Nanomotion Ltd. Of Yokneam, Israel, a Johnson Electric Company. Motors 201 can be arranged in separate housings 207 concentrically positioned around the drive mechanism 122 and each can include a drive tip 203 at one end that contacts the drive disk, such as ceramic drive disk 214, along a body portion 215 of the ceramic drive disk 214. Drive disk 214 can be configured, for example as shown in
The primary elements of the motor assembly utilized to translate the rotational motion of the ceramic drive disk 214 induced by the motors 201 into linear motion include a drive tube 202, a lead screw 204 and a drive nut or pushrod 206. As can be most clearly seen in
Various other components can be included in drive mechanism 122. Screws 237 extend from rear housing 228 to front housing 220 to retain device components together. Rear bearing 222 and a front bearing 224 can interface with the drive tube 202. A front seal 226 is provided between the front bearing 224 and guide bushing 218 to seal the interior of the drive mechanism 122. An additional sliding seal 247 that slides along the push rod 206 as it is advanced from the drive mechanism 122 can be included to provide redundant seals that prevent water and other liquid and/or contaminants such as dust, etc. from leaking into the system. Drive mechanism 122 can also include a flexible printed circuit board 230 that controls operation of the unit. In some embodiments, all electrical connections for each of the motors 201 can be contained on this flexible circuit board 230.
In one embodiment, operation of the unit is accomplished by energizing the piezoelectric motors with an electrical drive signal to cause them to oscillate against the ceramic drive disk 214. This oscillation induces rotational motion of the ceramic drive disk 214. Rotational motion of the ceramic drive disk 214 in a given direction causes the drive tube 202 and the lead screw 204 to rotate about a same or common axis of rotation 203. The intermeshing threaded exterior portion 212 of the lead screw 204 and interior threaded portion 217 of the pushrod 206 along with the non-circular perimeter 216 of the pushrod 206 that is constrained from rotating by the guide bushing 218 cause this rotational motion to be converted into linear motion of the pushrod 206. When the drive mechanism 122 is attached to a cartridge containing medicament, such as cartridge 116, the linear motion of the pushrod 206 causes the drive tip 234 of the pushrod to advance a syringe in the cartridge to cause medicament to be dispensed from the cartridge. Motors can be driven in parallel such that if one of the motors were turned off or not receiving the electrical drive signal, the non-energized motor would act as a friction brake due to the spring loading of the motor against the ceramic drive disk. The other two motors would continue to operate such that the system could still be in use with a non-functioning motor, however, the torque output would be significantly reduced relative to three operating motors. In other embodiments, greater or fewer than three motors can be employed, such as, for example two motors, with the number of motors affecting the amount of torque provided.
In some embodiments, drive mechanism 122 can further include a force transducer used to determine if the mechanism is functioning properly when activated to dispense medicament. Referring to
Further details regarding one embodiment of a cartridge 116 that can be used with patch pump 100 according to embodiments of the present invention are depicted in
There are a number of benefits provided by a patch pump such as described herein utilizing a piezoelectric drive mechanism as opposed to use of a conventional electromagnetic motor as in current patch pumps. A piezoelectric drive unit can be made smaller than an electromagnetic motor of the same capability and typically has fewer moving parts because no gear reduction is needed to generate the force required to drive the syringe to dispense medicament from the cartridge. In addition, a piezoelectric motor is capable of effecting micron-sized increments of motion that in turn allow for precise and small movements of the syringe without the need for a gear reduction system. A piezoelectric motor also can afford greater safety when acting to dispense medicaments such as, e.g., insulin, because such a motor can automatically brake the drive system when turned off or deactivated. This in turn can prevent the unintended dispensing of medicament. This braking effect is due in part to the friction that exists between the piezoelectric drive tip(s) and the ceramic drive disk. Another safety concern for syringe drive systems related to unintended motor movement is addressed with the system of the present invention because the piezoelectric motors require a specific AC drive signal, such that a short circuit in the system to a DC voltage source could not result in unintended motor movement.
As discussed herein, the terms gear reduction and gear transmission are used to refer to a system of one or more gears or other components that decrease the speed generated by the motor of an infusion pump system to increase the torque on the lead screw or syringe that causes medicament to be dispensed. Such a gear reduction system can include one or more gears, such as, e.g., spur gears, worm gears and/or planetary gears. A common conversion ratio is 256:1, meaning that the system transmits torque on the lead screw that is 256 times the torque generated by the motor. Other common conversion ratios range from 64:1 to 256:1. As noted above, no gear reduction is required to generate the force required to drive the lead screw in embodiments of the present invention because the disclosed piezoelectric-based system is capable of providing large enough torque and small enough rotational step size to achieve desirable infusion pressures and dispense delivery volumes. As such, the rotational output generated by the motor as reflected by the torque of the rotating drive disk is directly converted into torque on the lead screw in a generally 1:1 ratio. In other words, the high torque generated by the piezoelectric motors is directly converted into the same amount of torque on the lead screw, so no torque increasing gear reduction system is needed.
Because no gear reduction or gear transmission system is needed in embodiments of the present invention, the pushrod utilized to drive the syringe can be contained within and connected directly to the motor assembly. This “hollow motor” that is capable of containing the drive element for the system enables a syringe-type pump as described herein to be provided in a smaller size than has heretofore been possible with prior art electromagnetic-based syringe pumps and other pumps that utilized gear reduction systems. In one embodiment, the drive unit of the patch pump can weighs about 22 grams. In other embodiments, the drive unit of the patch pump can weigh from about 17 grams to about 27 grams. The cartridge can have a capacity of about two milliliters of medicament. In such an embodiment, the patch pump can weigh about 30 grams when the cartridge is full and attached to the drive unit. In other embodiments, the cartridge can have a capacity of from about one milliliter to about three or more milliliters of medicament.
An additional feature that can be utilized by a drive mechanism according to embodiments of the present invention is an optical encoder system. Referring to
In one embodiment, the optical encoder system can monitor three output channels that are indicated by the markings 242 on the drive tube 202. These can include, for example, an A channel, a B channel and an index channel. Monitoring of the A channel and the B channel can be used by the system to determine the rotational position, speed, and direction of rotation of the drive tube. Monitoring of the index channel can serve a number of purposes. For example, the index channel can be configured such that one index pulse is expected for a set number of A and B pulses. If the index channel pulse is not detected after the set number of A and B pulses, the encoder system is not operating properly, and one or more signals can be sent to a processor or other device to disable the drive system, send a warning or other message to a user, etc. Similarly, this configuration can be used to determine if the drive tube moved when the encoder system was not turned on. This configuration can further be used to determine if the A and B channels are operating as expected, because if so one index pulse should be received for each set number of A and B pulses as noted above. In the described optical encoder system, the markings 242 that are monitored are provided on a component of the system, drive tube 202, that otherwise serves an additional functional purpose (rotating the lead screw). As such, cost and complexity of the system are reduced by not requiring a separate, stand-alone part, such as a code wheel, for such monitoring. In addition, the electrical connections required for the encoder system can be provided on the same flexible circuit board 230 as the electrical connections for the motors 201, further reducing the cost and complexity of the system.
Referring to
Although primarily described herein as being employed in the context of a patch pump, it should be understood that the drive mechanism 122 described herein can be used with various other types of infusion pumps, such as, for example, the user-wearable infusion pumps described in the applications incorporated by reference herein.
Although the embodiments herein are specifically described with respect to the delivery of insulin, delivery of other medicaments, singly or in combination with one another or with insulin, including, for example, glucagon, pramlintide, etc., as well as other applications are also contemplated. Device and method embodiments discussed herein may be used for pain medication, chemotherapy, iron chelation, immunoglobulin treatment, dextrose or saline IV delivery, treatment of various conditions including, e.g., pulmonary hypertension, or any other suitable indication or application. Non-medical applications are also contemplated.
With regard to the above detailed description, like reference numerals used therein may refer to like elements that may have the same or similar dimensions, materials, and configurations. While particular forms of embodiments have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the embodiments herein. Accordingly, it is not intended that the invention be limited by the forgoing detailed description.
The entirety of each patent, patent application, publication, and document referenced herein is hereby incorporated by reference. Citation of the above patents, patent applications, publications and documents is not an admission that any of the foregoing is pertinent prior art, nor does it constitute any admission as to the contents or date of these documents.
Also incorporated herein by reference in their entirety are commonly owned U.S. Pat. Nos. 8,287,495; 8,408,421 8,448,824; 8,573,027; 8,650,937; 8,986,523; 9,173,998; 9,180,242; 9,180,243; 9,238,100; 9,242,043; and 9,335,910 commonly owned U.S. Patent Publication Nos. 2009/0287180; 2012/0123230; 2013/0053816; 2013/0159456; 2013/0324928; 2013/0331790; 2013/0332874; 2014/0273042; 2014/0276419; 2014/0276420; 2014/0276423; 2014/0276531; 2014/0276537; 2014/0276553; 2014/0276556 2014/0276569; 2014/0276570; 2014/0276574; 2014/0378898; 2015/0073337; 2015/0072613; 2015/0182693; 2015/0182694; 2015/0182695; 2016/0030669; and 2016/0082188 and commonly owned U.S. patent application Ser. Nos. 14/707,851 and 15/158,125 and commonly owned U.S. Provisional Application Ser. Nos. 61/911,576; 61/920,902; 61/920,914; 61/920,940; 62/139,275; 62/207,748; 62/256,398; 62/272,255; 62/300,410; and 62/352,164.
Further incorporated by reference herein in their entirety are U.S. Pat. Nos. 8,601,465; 8,502,662; 8,452,953; 8,451,230; 8,449,523; 8,444,595; 8,343,092; 8,285,328; 8,126,728; 8,117,481; 8,095,123; 7,999,674; 7,819,843; 7,782,192; 7,109,878; 6,997,920; 6,979,326; 6,936,029; 6,872,200; 6,813,519; 6,641,533; 6,554,798; 6,551,276; 6,295,506; and 5,665,065.
Modifications may be made to the foregoing embodiments without departing from the basic aspects of the technology. Although the technology may have been described in substantial detail with reference to one or more specific embodiments, changes may be made to the embodiments specifically disclosed in this application, yet these modifications and improvements are within the scope and spirit of the technology. The technology illustratively described herein may suitably be practiced in the absence of any element(s) not specifically disclosed herein. The terms and expressions which have been employed are used as terms of description and not of limitation and use of such terms and expressions do not exclude any equivalents of the features shown and described or portions thereof and various modifications are possible within the scope of the technology claimed. Although the present technology has been specifically disclosed by representative embodiments and optional features, modification and variation of the concepts herein disclosed may be made, and such modifications and variations may be considered within the scope of this technology.
This application is a continuation of application Ser. No. 15/241,257 filed Aug. 19, 2016, which claims the benefit of U.S. Provisional Application No. 62/207,748 filed Aug. 20, 2015, each of which is hereby incorporated herein in its entirety by reference.
Number | Name | Date | Kind |
---|---|---|---|
4019073 | Vishnevsky et al. | Apr 1977 | A |
4741736 | Brown | May 1988 | A |
5097122 | Colman et al. | Mar 1992 | A |
5236416 | McDaniel et al. | Aug 1993 | A |
5795327 | Wilson et al. | Aug 1998 | A |
6120460 | Abreu | Sep 2000 | A |
6158431 | Poole | Dec 2000 | A |
6362591 | Moberg | Mar 2002 | B1 |
6413254 | Hissong et al. | Jul 2002 | B1 |
6423035 | Das et al. | Jul 2002 | B1 |
6468242 | Wilson et al. | Oct 2002 | B1 |
6485465 | Moberg et al. | Nov 2002 | B2 |
6555986 | Moberg | Apr 2003 | B2 |
6659980 | Moberg et al. | Dec 2003 | B2 |
6669669 | Flaherty et al. | Dec 2003 | B2 |
6749587 | Flaherty | Jun 2004 | B2 |
6885881 | Leonhardt | Apr 2005 | B2 |
6913933 | Jacobs et al. | Jul 2005 | B2 |
6918542 | Silverbrook et al. | Jul 2005 | B2 |
6940209 | Henderson | Sep 2005 | B2 |
7064472 | Pelrine et al. | Jun 2006 | B2 |
7066909 | Peter et al. | Jun 2006 | B1 |
7073713 | Silverbrook et al. | Jul 2006 | B2 |
7083108 | Silverbrook et al. | Aug 2006 | B2 |
7092011 | Silverbrook et al. | Aug 2006 | B2 |
7097104 | Silverbrook et al. | Aug 2006 | B2 |
7107706 | Bailey, Sr. et al. | Sep 2006 | B1 |
7141812 | Appleby et al. | Nov 2006 | B2 |
7144384 | Gorman et al. | Dec 2006 | B2 |
7170214 | Henderson et al. | Jan 2007 | B2 |
7187404 | Silverbrook et al. | Mar 2007 | B2 |
7193521 | Moberg et al. | Mar 2007 | B2 |
7201319 | Silverbrook et al. | Apr 2007 | B2 |
7234645 | Silverbrook et al. | Jun 2007 | B2 |
7256824 | Silverbrook | Aug 2007 | B2 |
7289142 | Silverbrook | Oct 2007 | B2 |
7309943 | Henderson et al. | Dec 2007 | B2 |
7316700 | Alden et al. | Jan 2008 | B2 |
7339306 | Henderson | Mar 2008 | B2 |
7362971 | Silverbrook et al. | Apr 2008 | B2 |
7373083 | Silverbrook et al. | May 2008 | B2 |
7377706 | Silverbrook et al. | May 2008 | B2 |
7394182 | Pelrine et al. | Jul 2008 | B2 |
7411204 | Appleby et al. | Aug 2008 | B2 |
7460152 | Silverbrook et al. | Dec 2008 | B2 |
7464580 | Zeng et al. | Dec 2008 | B2 |
7475825 | Silverbrook et al. | Jan 2009 | B2 |
7483050 | Silverbrook et al. | Jan 2009 | B2 |
7497827 | Brister | Mar 2009 | B2 |
7517332 | Tonelli et al. | Apr 2009 | B2 |
7524045 | Silverbrook et al. | Apr 2009 | B2 |
7534226 | Mernoe et al. | May 2009 | B2 |
7551202 | Silverbrook | Jun 2009 | B2 |
7582063 | Wurster et al. | Sep 2009 | B2 |
7621893 | Moberg et al. | Nov 2009 | B2 |
7654127 | Krulevitch et al. | Feb 2010 | B2 |
7704227 | Moberg et al. | Apr 2010 | B2 |
7708717 | Estes et al. | May 2010 | B2 |
7713574 | Brister et al. | May 2010 | B2 |
7714889 | Silverbrook | May 2010 | B2 |
7736344 | Moberg et al. | Jun 2010 | B2 |
7744589 | Mounce et al. | Jun 2010 | B2 |
7766873 | Moberg et al. | Aug 2010 | B2 |
7774145 | Brauker et al. | Aug 2010 | B2 |
7776030 | Estes et al. | Aug 2010 | B2 |
7786648 | Xu et al. | Aug 2010 | B2 |
7794427 | Estes et al. | Sep 2010 | B2 |
7794428 | Estes et al. | Sep 2010 | B2 |
7806868 | De Polo et al. | Oct 2010 | B2 |
7887512 | Estes et al. | Feb 2011 | B2 |
7892206 | Moberg et al. | Feb 2011 | B2 |
7905868 | Moberg et al. | Mar 2011 | B2 |
7935104 | Yodfat et al. | May 2011 | B2 |
7938803 | Mernoe et al. | May 2011 | B2 |
7944366 | Krulevitch et al. | May 2011 | B2 |
7955295 | Lee et al. | Jun 2011 | B2 |
7963945 | Miller et al. | Jun 2011 | B2 |
7981084 | Estes et al. | Jul 2011 | B2 |
7988660 | Byland et al. | Aug 2011 | B2 |
7993109 | Rush et al. | Aug 2011 | B2 |
7998110 | Leung et al. | Aug 2011 | B2 |
7998111 | Moberg et al. | Aug 2011 | B2 |
8062257 | Moberg et al. | Nov 2011 | B2 |
8065096 | Moberg et al. | Nov 2011 | B2 |
8100852 | Moberg et al. | Jan 2012 | B2 |
8105279 | Mernoe et al. | Jan 2012 | B2 |
8182447 | Moberg et al. | May 2012 | B2 |
8187228 | Bikovsky | May 2012 | B2 |
8217533 | Jones et al. | Jul 2012 | B2 |
8267893 | Moberg et al. | Sep 2012 | B2 |
8282601 | Mernoe et al. | Oct 2012 | B2 |
8287495 | Michaud et al. | Oct 2012 | B2 |
8298184 | Diperna et al. | Oct 2012 | B2 |
8299733 | Sattler et al. | Oct 2012 | B2 |
8304960 | Sattler et al. | Nov 2012 | B2 |
8323188 | Tran | Dec 2012 | B2 |
8382703 | Abdelaal | Feb 2013 | B1 |
8414563 | Kamen et al. | Apr 2013 | B2 |
8450905 | Guidarelli et al. | May 2013 | B2 |
8466637 | Guidarelli et al. | Jun 2013 | B2 |
8517991 | Clemente | Aug 2013 | B2 |
8562590 | Yodfat et al. | Oct 2013 | B2 |
8573027 | Rosinko et al. | Nov 2013 | B2 |
8641671 | Michaud et al. | Feb 2014 | B2 |
8758323 | Michaud et al. | Jun 2014 | B2 |
8926561 | Verhoef et al. | Jan 2015 | B2 |
8986253 | Diperna | Mar 2015 | B2 |
9180243 | Michaud | Nov 2015 | B2 |
9211377 | Diperna et al. | Dec 2015 | B2 |
9362851 | Xu et al. | Jun 2016 | B2 |
9421329 | Kruse | Aug 2016 | B2 |
9555186 | Kruse | Jan 2017 | B2 |
9675756 | Kamen | Jun 2017 | B2 |
9962486 | Rosinko et al. | May 2018 | B2 |
9993595 | Michaud et al. | Jun 2018 | B2 |
10010674 | Rosinko et al. | Jul 2018 | B2 |
10279106 | Cook et al. | May 2019 | B1 |
10279107 | Michaud | May 2019 | B2 |
10357603 | Michaud et al. | Jul 2019 | B2 |
10850032 | Steck | Dec 2020 | B2 |
20030060768 | Kiyatake et al. | Mar 2003 | A1 |
20040204673 | Flaherty | Oct 2004 | A1 |
20040220551 | Flaherty et al. | Nov 2004 | A1 |
20050177111 | Ozeri et al. | Aug 2005 | A1 |
20060049720 | Henderson et al. | Mar 2006 | A1 |
20070093753 | Krulevitch et al. | Apr 2007 | A1 |
20070149926 | Moberg et al. | Jun 2007 | A1 |
20070156092 | Estes et al. | Jul 2007 | A1 |
20070167905 | Estes et al. | Jul 2007 | A1 |
20070173762 | Estes et al. | Jul 2007 | A1 |
20070270750 | Dacquay et al. | Nov 2007 | A1 |
20080045902 | Estes et al. | Feb 2008 | A1 |
20080045903 | Estes et al. | Feb 2008 | A1 |
20080045904 | Estes et al. | Feb 2008 | A1 |
20080045931 | Estes et al. | Feb 2008 | A1 |
20080051697 | Mounce et al. | Feb 2008 | A1 |
20080051698 | Mounce et al. | Feb 2008 | A1 |
20080051709 | Mounce et al. | Feb 2008 | A1 |
20080051711 | Mounce et al. | Feb 2008 | A1 |
20080051716 | Stutz | Feb 2008 | A1 |
20080051727 | Moberg | Feb 2008 | A1 |
20080097291 | Hanson et al. | Apr 2008 | A1 |
20080097375 | Bikovsky | Apr 2008 | A1 |
20080097381 | Moberg et al. | Apr 2008 | A1 |
20080125700 | Moberg et al. | May 2008 | A1 |
20080215035 | Yodfat et al. | Sep 2008 | A1 |
20080221523 | Moberg et al. | Sep 2008 | A1 |
20090036870 | Mounce et al. | Feb 2009 | A1 |
20090124994 | Roe | May 2009 | A1 |
20090157003 | Jones | Jun 2009 | A1 |
20090192724 | Brauker et al. | Jul 2009 | A1 |
20090270811 | Mounce et al. | Oct 2009 | A1 |
20100037680 | Moberg et al. | Feb 2010 | A1 |
20100078017 | Andrieux et al. | Apr 2010 | A1 |
20100121169 | Petisce et al. | May 2010 | A1 |
20100152674 | Kavazov et al. | Jun 2010 | A1 |
20100179402 | Goode, Jr. et al. | Jul 2010 | A1 |
20100185142 | Kamen et al. | Jul 2010 | A1 |
20100185175 | Kamen et al. | Jul 2010 | A1 |
20100198183 | Lanigan et al. | Aug 2010 | A1 |
20100211003 | Sundar | Aug 2010 | A1 |
20100217192 | Moberg et al. | Aug 2010 | A1 |
20100217193 | Moberg et al. | Aug 2010 | A1 |
20100249706 | Clemente | Sep 2010 | A1 |
20100324398 | Tzyy-Ping | Dec 2010 | A1 |
20110054390 | Searle et al. | Mar 2011 | A1 |
20110092948 | Shachar et al. | Apr 2011 | A1 |
20110144586 | Michaud et al. | Jun 2011 | A1 |
20110144616 | Michaud et al. | Jun 2011 | A1 |
20110152770 | Diperna et al. | Jun 2011 | A1 |
20110152824 | Diperna et al. | Jun 2011 | A1 |
20110152827 | Wiegel et al. | Jun 2011 | A1 |
20110160654 | Hanson et al. | Jun 2011 | A1 |
20110166544 | Verhoef et al. | Jul 2011 | A1 |
20110190614 | Brister et al. | Aug 2011 | A1 |
20110190694 | Lanier, Jr. et al. | Aug 2011 | A1 |
20110213329 | Yodfat et al. | Sep 2011 | A1 |
20110257895 | Brauker et al. | Oct 2011 | A1 |
20120000413 | Bruggermann et al. | Feb 2012 | A1 |
20120029433 | Michaud et al. | Feb 2012 | A1 |
20120029468 | Diperna | Feb 2012 | A1 |
20120030610 | Diperna et al. | Feb 2012 | A1 |
20120096954 | Vazquez et al. | Apr 2012 | A1 |
20120172817 | Bruggemann et al. | Jul 2012 | A1 |
20120259282 | Alderete, Jr. | Oct 2012 | A1 |
20130053816 | Diperna et al. | Feb 2013 | A1 |
20130150766 | Olde | Jun 2013 | A1 |
20130204542 | Olde | Aug 2013 | A1 |
20130324928 | Kruse | Dec 2013 | A1 |
20130331790 | Brown et al. | Dec 2013 | A1 |
20140039392 | Geipel et al. | Feb 2014 | A1 |
20140054883 | Lanigan et al. | Feb 2014 | A1 |
20140276423 | Lecanu-Fayet | Sep 2014 | A1 |
20150174320 | Grant | Jun 2015 | A1 |
20150202375 | Schabbach et al. | Jul 2015 | A1 |
20160051758 | Rosinko et al. | Feb 2016 | A1 |
20160082186 | Rosinko et al. | Mar 2016 | A1 |
20160136357 | Yang | May 2016 | A1 |
20160157759 | Yang | Jun 2016 | A1 |
20160157765 | Zhu | Jun 2016 | A1 |
20160158436 | Yang | Jun 2016 | A1 |
20160199572 | Yang | Jul 2016 | A1 |
20160339172 | Michaud et al. | Nov 2016 | A1 |
20170049957 | Michaud | Feb 2017 | A1 |
20170056581 | Deak et al. | Mar 2017 | A1 |
20180071454 | Betts et al. | Mar 2018 | A1 |
20180264189 | Michaud et al. | Sep 2018 | A1 |
20190240398 | Seitz et al. | Aug 2019 | A1 |
20190321546 | Michaud et al. | Oct 2019 | A1 |
Number | Date | Country |
---|---|---|
2930776 | May 2018 | CA |
1097632 | Jan 1995 | CN |
1611001 | Apr 2005 | CN |
101563120 | Oct 2009 | CN |
101745163 | Dec 2013 | CN |
2420274 | Feb 2012 | EP |
2510960 | Oct 2012 | EP |
WO-0228532 | Apr 2002 | WO |
WO-2008024808 | Feb 2008 | WO |
WO-2008024812 | Feb 2008 | WO |
WO-2009013736 | Jan 2009 | WO |
WO-2009016636 | Feb 2009 | WO |
WO-2010096449 | Aug 2010 | WO |
Entry |
---|
Extended European Search Report for Application No. 16837895.8, dated Nov. 7, 2018, 8 pages. |
International Preliminary Report on Patentability for Application No. PCT/US2016/047725, dated Mar. 1, 2018, 8 pages. |
International Search Report and Written Opinion for Application No. PCT/US2016/047725, dated Nov. 28, 2016, 12 pages. |
International Search Report and Written Opinion for Application No. PCT/US2019/016466, dated May 22, 2019, 13 pages. |
Application and File history for U.S. Appl. No. 16/266,471, filed Feb. 4, 2019. Inventors: Seitz et al. |
Application and File history for U.S. Appl. No. 15/241,257, filed Aug. 19, 2016. Inventors: Michaud. |
Office Action dated Dec. 11, 2019 for Chinese Application No. 201680061057.X, 17 pages. |
Communication dated Feb. 17, 2020 for EP Application 16837895.8, 5 pages. |
Number | Date | Country | |
---|---|---|---|
20190255248 A1 | Aug 2019 | US |
Number | Date | Country | |
---|---|---|---|
62207748 | Aug 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15241257 | Aug 2016 | US |
Child | 16403016 | US |